Bolt Medical Announces Completion of Enrollment of RESTORE ATK Pivotal Trial for the Unique Bolt Intravascular Lithotripsy System

Bolt Medical completes the enrollment of RESTORE ATK pivotal trial for the treatment of peripheral arterial disease with its unique intravascular lithotripsy system. CARLSBAD, Calif., April 22, 2024 /PRNewswire-PRWeb/ -- Bolt Medical, Inc., a clinical stage medical device company is...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Tags: TRI Source Type: news